GENFIT Announces EMA Support for Iqirvo® in PBC Treatment
Jul 27, 2024
Ema Investment Portfolios
Amgen Prepares for Teprotumumab Application Submission to EMA
Apr 27, 2024
Ipsen Announces FDA's Priority Review of Elafibranor for PBC Treatment, with EMA Also Validating MAA
Dec 7, 2023